AHA24 Screening for Kidney Disease to Reduce CVD Risk: uACR and eGFR

Contributing Authors	4
Introduction	6
Causation	8
Pathophysiology and Outcomes	8
Prevalence and Incidence of Undetected CKD	10
Individuals With CVD	11
Individuals With Diabetes and Others at Risk for CVD	11
Early Testing Can Improve Clinical Outcomes	12
Undetected CVD in Those With Known CKD	14
People Living With Diabetes	15
Use Guideline-Directed Medical Therapy and Shared Decision-Making to Improve Outcomes	16
Barriers to Guideline-Directed Medical Therapy	17
Screening and Staging CKM	18
Act Now	19
Key Takeaways	20
Key for Toolkit Terms	21

RkJQdWJsaXNoZXIy MjI2NjI=